Literature DB >> 31896499

International Pediatric ORL Group (IPOG) Robin Sequence consensus recommendations.

Pierre Fayoux1, Sam J Daniel2, Gregory Allen3, Karthik Balakrishnan4, An Boudewyns5, Alan Cheng6, Alessandro De Alarcon7, Dimple Goel8, Catherine K Hart7, Nicolas Leboulanger9, Gi Lee10, Eric Moreddu11, Harlan Muntz12, Reza Rahbar10, Richard Nicollas11, Carolyn R Rogers-Vizena13, John Russell14, Michael J Rutter7, Richard J H Smith15, Michelle Wyatt16, George Zalzal17, Cory M Resnick13.   

Abstract

OBJECTIVE: To provide recommendations for the comprehensive management of airway obstruction in patients with Robin Sequence.
METHODS: Expert opinion by the members of the International Pediatric Otolaryngology Group (IPOG).
RESULTS: The consensus statement provides recommendations for medical specialists who manage infants with Robin Sequence including: evaluation and treatment considerations for commonly debated issues in post-natal airway obstruction, assessment of antenatal obstruction and perinatal airway management.
CONCLUSION: Consensus recommendations are aimed at improving management of airway obstruction in patients with Robin Sequence.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway; Assessment; Robin sequence; Swallowing; Treatment

Mesh:

Year:  2019        PMID: 31896499     DOI: 10.1016/j.ijporl.2019.109855

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin Sequence.

Authors:  Austin S Lam; Michael D Bindschadler; Kelly N Evans; Seth D Friedman; Matthew S Blessing; Randall Bly; Michael L Cunningham; Mark A Egbert; Russell E Ettinger; Emily R Gallagher; Richard A Hopper; Kaalan Johnson; Jonathan A Perkins; Erin K Romberg; Kathleen C Y Sie; Srinivas M Susarla; Carlton J Zdanski; Xing Wang; Jeffrey P Otjen; Francisco A Perez; John P Dahl
Journal:  Otolaryngol Head Neck Surg       Date:  2021-07-13       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.